AllianceBernstein
SLDB icon

AllianceBernstein’s Solid Biosciences SLDB Stock Holding History

AllianceBernstein’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$499K Hold
69,260
– – ﹤0.01% 2715
2026
Q1 		$391K Sell
69,260
-12,570
-15% -$80.8K ﹤0.01% 2761
2025
Q4 		$462K Hold
81,830
– – ﹤0.01% 2695
2025
Q3 		$505K Hold
81,830
– – ﹤0.01% 2669
2025
Q2 		$399K Buy
81,830
+66,230
+425% +$234K ﹤0.01% 2779
2025
Q1 		$57.7K Hold
15,600
– – ﹤0.01% 3117
2024
Q4 		$62.4K Hold
15,600
– – ﹤0.01% 3172
2024
Q3 		$109K Hold
15,600
– – ﹤0.01% 3123
2024
Q2 		$88.5K Buy
+15,600
New +$140K ﹤0.01% 3132
2022
Q2 		– Sell
-3,113
Closed -$56K – 3367
2022
Q1 		$56K Sell
3,113
-767
-20% -$13.5K ﹤0.01% 3169
2021
Q4 		$102K Hold
3,880
– – ﹤0.01% 3194
2021
Q3 		$139K Hold
3,880
– – ﹤0.01% 3154
2021
Q2 		$213K Buy
3,880
+1,427
+58% +$94.3K ﹤0.01% 3140
2021
Q1 		$204K Sell
2,453
-354
-13% -$39.2K ﹤0.01% 3060
2020
Q4 		$319K Sell
2,807
-920
-25% -$58.2K ﹤0.01% 2829
2020
Q3 		$113K Sell
3,727
-600
-14% -$23K ﹤0.01% 3060
2020
Q2 		$190K Buy
4,327
+660
+18% +$27.4K ﹤0.01% 3017
2020
Q1 		$131K Buy
3,667
+294
+9% +$14.5K ﹤0.01% 2905
2019
Q4 		$225K Hold
3,373
– – ﹤0.01% 2885
2019
Q3 		$523K Buy
3,373
+500
+17% +$56.6K ﹤0.01% 2524
2019
Q2 		$248K Buy
2,873
+600
+26% +$65.4K ﹤0.01% 2896
2019
Q1 		$314K Buy
2,273
+806
+55% +$202K ﹤0.01% 2738
2018
Q4 		$590K Hold
1,467
– – ﹤0.01% 2408
2018
Q3 		$1.04M Buy
1,467
+307
+26% +$193K ﹤0.01% 2314
2018
Q2 		$620K Buy
+1,160
New +$357K ﹤0.01% 2534

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AllianceBernstein's SLDB Position: Q2 2026 in Review

AllianceBernstein held its Solid Biosciences (SLDB) position steady in Q2 2026 at 69,260 shares worth $499K. The position accounts for ﹤0.01% of the portfolio, ranked #2715.

AllianceBernstein first reported a position in SLDB in Q2 2018 and has held it in 25 quarters since. The position peaked at $1.04M in Q3 2018. 157 funds tracked by Wall St. Rank hold SLDB as of Q2 2026.

  • AllianceBernstein held 69,260 shares of Solid Biosciences worth $499K as of Q2 2026.
  • AllianceBernstein left its Solid Biosciences share count unchanged in Q2 2026.
  • Solid Biosciences made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2715 holding.
  • AllianceBernstein first reported a position in Solid Biosciences in Q2 2018 and has held it in 25 quarters since.
  • AllianceBernstein's Solid Biosciences position peaked at $1.04M in Q3 2018.
  • 157 funds tracked by Wall St. Rank held Solid Biosciences as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.